Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease (Q62035320)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease |
clinical trial |
Statements
A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical Study to Evaluate the Efficacy and Safety of Trehalose in Patients With Fatty Liver Disease (English)
0 references
30 June 2016
0 references
20 March 2018
0 references
39
0 references
19 year
0 references
79 year
0 references